Barclays
SHC icon

Barclays’s Sotera Health SHC Stock Holding History

Barclays’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.2M Buy
550,275
+354,418
+181% +$6.54M ﹤0.01% 1634
2026
Q2 		$3.48M Buy
195,857
+66,235
+51% +$1.04M ﹤0.01% 2039
2026
Q1 		$1.86M Sell
129,622
-61,107
-32% -$1.01M ﹤0.01% 2395
2025
Q4 		$3.36M Sell
190,729
-90,366
-32% -$1.49M ﹤0.01% 2537
2025
Q3 		$4.42M Buy
281,095
+32,787
+13% +$460K ﹤0.01% 2301
2025
Q2 		$2.76M Buy
248,308
+148,431
+149% +$1.74M ﹤0.01% 2596
2025
Q1 		$1.16M Sell
99,877
-49,854
-33% -$642K ﹤0.01% 3020
2024
Q4 		$2.05M Sell
149,731
-323,866
-68% -$4.69M ﹤0.01% 2853
2024
Q3 		$7.91M Buy
473,597
+298,085
+170% +$4.35M ﹤0.01% 1658
2024
Q2 		$2.08M Sell
175,512
-81,570
-32% -$931K ﹤0.01% 2109
2024
Q1 		$3.09M Buy
257,082
+21,328
+9% +$317K ﹤0.01% 2205
2023
Q4 		$3.97M Buy
235,754
+137,404
+140% +$1.95M ﹤0.01% 2310
2023
Q3 		$1.47M Sell
98,350
-19,745
-17% -$333K ﹤0.01% 2075
2023
Q2 		$2.22M Buy
118,095
+103,322
+699% +$1.64M ﹤0.01% 1820
2023
Q1 		$265K Sell
14,773
-11,695
-44% -$195K ﹤0.01% 3643
2022
Q4 		$220K Buy
26,468
+3,297
+14% +$24.6K ﹤0.01% 3782
2022
Q3 		$158K Buy
23,171
+7,773
+50% +$129K ﹤0.01% 3336
2022
Q2 		$302K Buy
15,398
+13,863
+903% +$290K ﹤0.01% 3194
2022
Q1 		$33K Buy
+1,535
New +$32.6K ﹤0.01% 4277

Other funds holding SHC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Sculptor Capital
Sculptor Capital New York $10.4B AUM 27.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Barclays's SHC Position: Q3 2026 in Review

Barclays increased its Sotera Health (SHC) stake by 181% in Q3 2026, buying an estimated $6.54M and bringing the position to 550,275 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1634.

Barclays first reported a position in SHC in Q1 2022 and has held it in 19 quarters since. 261 funds tracked by Wall St. Rank hold SHC as of Q3 2026.

  • Barclays held 550,275 shares of Sotera Health worth $10.2M as of Q3 2026.
  • Barclays bought 354,418 Sotera Health shares in Q3 2026, an estimated $6.54M.
  • Sotera Health made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1634 holding.
  • Barclays first reported a position in Sotera Health in Q1 2022 and has held it in 19 quarters since.
  • 261 funds tracked by Wall St. Rank held Sotera Health as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.